NPPB and type 2 diabetes mellitus: Our results of similar significant decreases in BNP concentration over time between the DPP-4i and placebo groups are in line with findings demonstrated by Jarolim et al. [45] evaluating patients with T2DM randomized to alogliptin or placebo between 15 and 90 days after an acute coronary syndrome.